FDA Inspection
Thrombolysis in Myocardial Infarction (TIMI) Study GroupFDA Inspection 1029812 - Thrombolysis in Myocardial Infarction (TIMI) Study Group - October 12, 2017
Discuss this record with AI
Record Details
This FDA Inspection record concerns Thrombolysis in Myocardial Infarction (TIMI) Study Group, with an inspection on October 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 12, 2017
- Product Type
- Drugs
Open in Dashboard
ID · 8b28f4f4-962d-4eb0-a1d2-559d2dd86144